Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07391410 · ClinicalTrials.gov registry record
Registry for Bone Metastases
A clinical trial of Bone Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 7
- Study locations
NCT07391410 is a study of Bone Metastases that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 500 participants, above the 104-participant average among 10 other Bone Metastases trials with a reported enrollment target (381% higher). The trial reports 7 study locations across 2 states.
The verdict
NCT07391410, a study of Bone Metastases, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.
Conditions Studied
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2031-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07391410
The ClinicalTrials.gov registry entry for NCT07391410 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 104-participant average among 10 other Bone Metastases trials with a reported enrollment target (381% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 0 interventions.
NCT07391410 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07391410 about?
NCT07391410 is a clinical study titled "Registry for Bone Metastases". The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a sp...
What is the current status of trial NCT07391410?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-01-13. Estimated completion is 2031-01.
What conditions does trial NCT07391410 study?
This clinical trial studies the following conditions: Bone Metastases.
Who is sponsoring clinical trial NCT07391410?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07391410 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
RECRUITING · NA
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
RECRUITING · Phase 3
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
FDG PET/CT in Breast Cancer Bone Mets
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.